ERBB2 and cancer: To assess the impact of treatment burden, patients were asked, “which side effects of your current treatment are the most difficult to manage on a daily basis?” To assess their parallel views on the topic, oncologists were asked, “in your opinion, what are the most difficult side effects related to treatments for patients with metastatic HER2-positive cancer to manage?”